Frank Nunes

Frank Nunes

Auto-generated profile, based on publicly available information

Frank Nunes

HOSPITAL CÉSAR LEITE

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2024 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
FNFrank Nunes
Frank Nunes
BGBreno Moreno de Gusmão
Breno Moreno de Gusmão
FWFranciely Bueno Wiginesk
Franciely Bueno Wiginesk
EMEuler Manenti
Euler Manenti
JSJuliana Soares
Juliana Soares
AMAriane Vieira Scarlatelli Macedo
Ariane Vieira Scarlatelli Macedo
Chimeric antigen receptor T-cell therapy represents an innovative approach to immunotherapy and currently stands out, particularly for oncohematological patients refractory to traditional treatments. Ongoing trials are further expanding its clinical use for new oncological and non-oncological indications, potentially leading to newer treatment options soon. This new approach, however, also presents challenges, including cardiovascular toxicity. Little is reported in pivotal studies, and some recent retrospective observations suggest a non-negligible incidence of side effects with presentation ranging from mild adverse cardiovascular events to fatal complications in which, in most cases, there is a direct or indirect association with cytokine release syndrome. In this literature review, the hypotheses of an important interface between cytokine release syndrome and cardiotoxicity by chimeric antigen receptor T-cell therapy will be addressed, as will current knowledge about risk factors for cardiotoxicity and recommendations for pre-therapy evaluation, post-infusion monitoring and clinical management of these complications.

1 March 2025 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
CRCristhian Espinoza Romero
Cristhian Espinoza Romero
FFFabio Fernandes
Fabio Fernandes
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
FNFrank Nunes
Frank Nunes
Danon disease is a rare genetic disorder associated with mutations in the LAMP2 gene, located on the X chromosome, which encodes the LAMP2 protein that is essential for autophagy. The disease is characterized by a triad of cardiomyopathy, skeletal myopathy, and intellectual disability, with clinical manifestations that vary between the sexes. Men generally present with more severe and earlier forms, with hypertrophic cardiomyopathy and arrhythmias, whereas women present with later progression and less homogeneous symptoms. To illustrate the wide [...] Abstract Danon disease is a rare genetic disorder associated with mutations in the LAMP2 gene, located on the X chromosome, which encodes the LAMP2 protein that is essential for autophagy. The disease is characterized by a triad of cardiomyopathy, skeletal myopathy, and intellectual disability, with clinical manifestations that vary between the sexes. Men generally present with more severe and earlier forms, with hypertrophic cardiomyopathy and arrhythmias, whereas women present with later progression and less homogeneous symptoms. To illustrate the wide

20 October 2025 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
FNFrank Nunes
Frank Nunes
RCRaquel Germer Toja Couto
Raquel Germer Toja Couto
DADiane Xavier de Avila
Diane Xavier de Avila
ATAna Flavia Malheiros Torbey
Ana Flavia Malheiros Torbey
KLKárila Scarduelli Luciano
Kárila Scarduelli Luciano
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
Filamin C is an essential protein for the integrity of the sarcomere and cytoskeleton of cardiomyocytes. Pathogenic variants in the FLNC gene are associated with a wide range of cardiomyopathies and may present distinct phenotypes depending on the type of genetic alteration. Truncated variants are frequently associated with dilated and arrhythmogenic cardiomyopathy, while missense variants are more related to hypertrophic and restrictive forms. These phenotypic differences reflect the molecular and structural impact of the FLNC variant on filamin C [...] Abstract Filamin C is an essential protein for the integrity of the sarcomere and cytoskeleton of cardiomyocytes. Pathogenic variants in the FLNC gene are associated with a wide range of cardiomyopathies and may present distinct phenotypes depending on the type of genetic alteration. Truncated variants are frequently associated with dilated and arrhythmogenic cardiomyopathy, while missense variants are more related to hypertrophic and restrictive forms. These phenotypic differences reflect the molecular and structural impact of the FLNC variant on filamin C

1 March 2025 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
CRCristhian Espinoza Romero
Cristhian Espinoza Romero
FFFabio Fernandes
Fabio Fernandes
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
FNFrank Nunes
Frank Nunes
Danon disease is a rare genetic disorder associated with mutations in the LAMP2 gene, located on the X chromosome, which encodes the LAMP2 protein that is essential for autophagy. The disease is characterized by a triad of cardiomyopathy, skeletal myopathy, and intellectual disability, with clinical manifestations that vary between the sexes. Men generally present with more severe and earlier forms, with hypertrophic cardiomyopathy and arrhythmias, whereas women present with later progression and less homogeneous symptoms. To illustrate the wide [...] Abstract Danon disease is a rare genetic disorder associated with mutations in the LAMP2 gene, located on the X chromosome, which encodes the LAMP2 protein that is essential for autophagy. The disease is characterized by a triad of cardiomyopathy, skeletal myopathy, and intellectual disability, with clinical manifestations that vary between the sexes. Men generally present with more severe and earlier forms, with hypertrophic cardiomyopathy and arrhythmias, whereas women present with later progression and less homogeneous symptoms. To illustrate the wide

1 June 2023 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Closed access
PDF file
EFESTEVAO LANNA FIGUEIREDO
ESTEVAO LANNA FIGUEIREDO
FNFrank Nunes
Frank Nunes
FNFernando Carvalho Neuenschwander
Fernando Carvalho Neuenschwander
KMKleisson Antônio Pontes Maia
Kleisson Antônio Pontes Maia
ACAndré Assis Lopes Do Carmo
André Assis Lopes Do Carmo
Recently, pre-excitation syndromes, left bundle branch block (LBBB), and right ventricular pacing have been recognized as causes of cardiomyopathies (CMs). They all have abnormal ventricular activation, that results in what is known as left ventricular (LV) dyssynchrony. These three entities show a common feature of wide QRS and LBBB pattern on the electrocardiogram. The term abnormal conduction-induced CM was, then, proposed. Appropriate diagnosis and treatment of these CMs will possibly improve LV ejection fraction, LV functional capacity and reduce [...] Abstract Recently, pre-excitation syndromes, left bundle branch block (LBBB), and right ventricular pacing have been recognized as causes of cardiomyopathies (CMs). They all have abnormal ventricular activation, that results in what is known as left ventricular (LV) dyssynchrony. These three entities show a common feature of wide QRS and LBBB pattern on the electrocardiogram. The term abnormal conduction-induced CM was, then, proposed. Appropriate diagnosis and treatment of these CMs will possibly improve LV ejection fraction, LV functional capacity and reduce

20 October 2025 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
FNFrank Nunes
Frank Nunes
RCRaquel Germer Toja Couto
Raquel Germer Toja Couto
DADiane Xavier de Avila
Diane Xavier de Avila
ATAna Flavia Malheiros Torbey
Ana Flavia Malheiros Torbey
KLKárila Scarduelli Luciano
Kárila Scarduelli Luciano
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
A Filamina C é uma proteína essencial para a integridade do sarcômero e do citoesqueleto dos cardiomiócitos. Variantes patogênicas no gene FLNC estão associadas a uma ampla gama de cardiomiopatias, podendo apresentar fenótipos distintos de acordo com o tipo de alteração genética. As variantes truncadas estão frequentemente associadas à cardiomiopatia dilatada e arritmogênica, enquanto as variantes missense são mais relacionadas às formas hipertrófica e restritiva. Essas diferenças fenotípicas refletem o impacto molecular e estrutural da variante FLNC na proteína filamina C, com implicações diretas no manejo clínico. O diagnóstico e a estratificação de risco são desafiadores e exigem uma abordagem multimodal que integre dados clínicos, genéticos e de imagem. A ressonância magnética cardíaca, em especial, é fundamental para a detecção de fibrose miocárdica e para a avaliação prognóstica. Evidências recentes indicam que variantes patogênicas no FLNC também podem estar associadas, raramente, a casos de miocardite aguda de apresentação grave, frequentemente acompanhada de arritmias ventriculares malignas e disfunção sistólica. O diagnóstico preciso, o acompanhamento contínuo e o aconselhamento familiar são fundamentais para definir a melhor abordagem terapêutica e prognóstica dos pacientes, em especial daqueles com alto risco de morte súbita cardíaca (MSC), permitindo desta forma, intervenções personalizadas e preventivas.